Medical Properties Trust, Inc. (NYSE:MPW) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, August 3rd.
Several other equities analysts also recently commented on the company. Jefferies Group LLC upgraded Medical Properties Trust from a “hold” rating to a “buy” rating and raised their target price for the stock from $13.00 to $15.00 in a research report on Friday, April 7th. Zacks Investment Research upgraded Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 target price for the company in a research report on Wednesday, July 19th. Deutsche Bank AG raised their target price on Medical Properties Trust from $13.50 to $15.00 and gave the stock a “buy” rating in a research report on Thursday, April 6th. BidaskClub downgraded Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Finally, Royal Bank Of Canada restated a “buy” rating on shares of Medical Properties Trust in a research report on Monday, May 15th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $14.20.
Medical Properties Trust (NYSE:MPW) traded up 0.64% during trading on Thursday, reaching $12.52. The company had a trading volume of 2,431,415 shares. The company has a market capitalization of $4.38 billion, a P/E ratio of 15.31 and a beta of 0.89. The stock has a 50 day moving average of $12.83 and a 200-day moving average of $13.04. Medical Properties Trust has a 12 month low of $11.54 and a 12 month high of $15.74.
Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.32 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.32. The company had revenue of $166.80 million during the quarter, compared to the consensus estimate of $163.08 million. Medical Properties Trust had a return on equity of 7.54% and a net margin of 42.25%. The company’s quarterly revenue was up 32.1% on a year-over-year basis. During the same quarter last year, the company earned $0.32 EPS. Equities research analysts expect that Medical Properties Trust will post $0.88 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Medical Properties Trust, Inc. (MPW) Upgraded at ValuEngine” was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://stocknewstimes.com/2017/08/13/valuengine-upgrades-medical-properties-trust-inc-mpw-to-buy-updated.html.
In other news, CFO R Steven Hamner sold 85,000 shares of Medical Properties Trust stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $13.36, for a total value of $1,135,600.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.00% of the stock is currently owned by company insiders.
Large investors have recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. boosted its stake in Medical Properties Trust by 25.2% in the first quarter. Goldman Sachs Group Inc. now owns 1,653,360 shares of the real estate investment trust’s stock valued at $21,311,000 after buying an additional 332,602 shares during the period. Swiss National Bank boosted its stake in Medical Properties Trust by 6.2% in the first quarter. Swiss National Bank now owns 527,700 shares of the real estate investment trust’s stock valued at $6,802,000 after buying an additional 30,800 shares during the period. Stratos Wealth Partners LTD. boosted its stake in Medical Properties Trust by 13.4% in the first quarter. Stratos Wealth Partners LTD. now owns 26,293 shares of the real estate investment trust’s stock valued at $339,000 after buying an additional 3,112 shares during the period. HighTower Advisors LLC boosted its stake in Medical Properties Trust by 31.6% in the first quarter. HighTower Advisors LLC now owns 42,198 shares of the real estate investment trust’s stock valued at $546,000 after buying an additional 10,140 shares during the period. Finally, Teacher Retirement System of Texas boosted its stake in Medical Properties Trust by 2.7% in the first quarter. Teacher Retirement System of Texas now owns 25,175 shares of the real estate investment trust’s stock valued at $325,000 after buying an additional 665 shares during the period. 78.48% of the stock is owned by institutional investors.
About Medical Properties Trust
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
